Search
for
Sort by
Research 871–900 of 1000+
- Protective effect of DA-9401 in finasteride-induced apoptosis in rat testis: inositol requiring kinase 1 and c-Jun N-terminal kinase pathway
- ODP265 Bph, Androgenic Alopecia, and Acne – Markers of Progesterone Deficiency
- Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients
- Relationship between androgenic alopecia and white matter hyperintensities in apparently healthy subjects
- COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations
- Finasteride use in the male infertility population: effects on semen and hormone parameters
- Physicochemical Characterization of Finasteride Nanosystem for Enhanced Topical Delivery
- Increased DHEAS and Decreased Total Testosterone Serum Levels in a Subset of Men with Early-Onset Androgenetic Alopecia: Does a Male PCOS-Equivalent Exist?
- Imaging to study solid tumour origin and progression: lessons from research and clinical oncology
- Black phosphorus nanosheets encapsulated microneedle for multifunctional therapy for androgenic alopecia
- Design of Nanocrystalline Suspension of Dutasteride for Intramuscular Prolonged Delivery
- Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools
- Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
- May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
- The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model
- Higher Levels of Serum Uric Acid Have a Significant Association with Lower Incidence of Lower Urinary Tract Symptoms in Healthy Korean Men
- WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH
- Kombinationsbehandlung des BPS mit Tamsulosin und Finasterid
- An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications
- Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
- Genetic Disorders and Defects in Vitamin D Action
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- Visualising Androgen Receptor Activity in Male and Female Mice
- Targeting integrin pathways: mechanisms and advances in therapy
- JMJD3 and NF-κB-dependent activation of Notch1 gene is required for keratinocyte migration during skin wound healing
- Integrative analysis reveals ncRNA-mediated molecular regulatory network driving secondary hair follicle regression in cashmere goats
- Mechanisms of Action of Dehydroepiandrosterone
- Finasteride: the first 5 alpha-reductase inhibitor.
- Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
- Rooster feathering, androgenic alopecia, and hormone-dependent tumor growth: What is in common?